Loading
Cancer, Hypoxia, and Metabolism / Ferroptosis and Cancer Prognosis · Journal article
Cancer Cell International · August 14, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review of the regulatory interplay between non-coding RNAs and solute carrier family transporters in cancer metabolism. It synthesizes existing mechanistic literature and identifies knowledge gaps rather than reporting new empirical findings or clinical outcomes.
Narrative review. Cancer cells and tumors (in vitro and theoretical).
Non-coding RNAs (microRNAs, long non-coding RNAs, circular RNAs) regulate SLC transporter expression and function SLC transporters mediate amino acid and sugar uptake required for cancer cell growth and survival Dysregulation of SLC transporters contributes to metabolic reprogramming, tumor progression, and therapy resistance
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This review identifies a therapeutic target area (ncRNA-SLC networks) that may warrant investigation but does not provide evidence sufficient to guide clinical practice or validate specific interventions.
This is a narrative review synthesizing existing literature on ncRNA regulation of SLC transporters in cancer, raising mechanistic questions rather than presenting new empirical evidence or a definitive answer.
As stated by the source record.
This review identifies a therapeutic target area (ncRNA-SLC networks) that may warrant investigation but does not provide evidence sufficient to guide clinical practice or validate specific interventions.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Solute carrier (SLC) transporters play a central role in tumor metabolism by mediating the uptake of amino acids and sugars required for cancer cell growth and survival. Their proper function is crucial for maintaining cellular homeostasis, and their dysregulation contributes to metabolic reprogramming, tumor progression, and therapy resistance. Recent studies have identified non-coding RNAs (ncRNAs), including microRNAs, long non-coding RNAs, and circular RNAs, as key regulators of SLC transporter expression and function. This review provides a focused and comprehensive overview of the intricate regulatory networks between ncRNAs and amino acid and sugar transporters within the SLC family, highlighting their implications in cancer. We summarize current evidence on direct and indirect regulatory mechanisms, including transcriptional, post-transcriptional, and epigenetic pathways, and discuss how these interactions reshape cancer metabolism. We highlight existing knowledge gaps, such as context-dependent regulation, indirect regulatory networks, and limited mechanistic validation in vivo. Finally, we discuss the therapeutic potential and challenges of targeting ncRNA-SLC networks. A deeper understanding of these interactions may facilitate the development of novel therapeutic approaches aimed at improving cancer treatment outcomes.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.